Michael J. Reardon, MD

Allison Family Distinguished Chair In Cardiovascular Research, Department of Cardiovascular Surgery
Professor of Cardiovascular Surgery, Academic Institute
Full Member, Research Institute
Houston Methodist
Weill Cornell Medical College


Dr. Michael J. Reardon is a native Houstonian who attended Baylor College of Medicine where he graduated with honors and as a member of AOA. He did his general surgery residency under Dr. Michael DeBakey and cardiothoracic residency under Dr. Denton Cooley. He joined the staff of the Houston Methodist Hospital in 1985 and ran a private practice until 1993. He then joined the full time faculty of BCM rising to Professor of Surgery with tenure, Chief of Cardiothoracic Surgery and Director of the thoracic residency program. He subsequently joined the academic group at the HMH as Professor of Cardiothoracic Surgery and Chief of Cardiac Surgery.

His interests have centered on aortic surgery, cardiac valve surgery and cardiac tumors. His recent research and clinical interests have focused on minimally invasive, catheter-based approaches to these areas. He serves on the national steering committee for the CoreValve, SurTAVI and reprise III TAVR trials and as national surgical PI on the SurTAVI trial, reprise III trial and the Gore type A dissection trial. Dr. Reardon also serves as the international surgical PI for the Reprise III trial.

He holds the position of Clinical Professor of Cardiothoracic Surgery at MD Anderson Cancer Center and created the multi-institution, multidisciplinary cardiac tumor team with HMH and MDA. He has operated on more primary cardiac sarcomas than any other surgeon globally and written extensively on this topic. Dr. Reardon's group recently published the largest series of surgically treated primary cardiac sarcomas in the world. Surgical Treatment of Primary Cardiac Sarcomas: Review of a Single-Institution Experience PMID 26476808

He has served as elected president of the medical staff for the HMH and received numerous awards including the Overstreet Award and Noon Award. He currently holds the Allison Family Distinguished Chair of Cardiovascular Research and divides his time between building innovative clinical, research and educational programs.

Description of Research

He has been the principal and co-investigator on several industry and government-sponsored clinical trials and research initiatives, and he is currently on the national steering and screening committees for the Medtronic CoreValve US Pivotal Trial and the international steering committee for the SurTAVI Trial, for which he is also a national surgical principal investigator. His research interests include cardiac tumor treatment, catheter based approaches to structural heart disease, catheter based and open aortic disease treatment Having published more than 300 articles and abstracts, Dr. Reardon conducts peer reviews for publications such as the Annals of Thoracic Surgery and Circulation and is the associate editor of surgery for the Methodist DeBakey Cardiovascular Journal.

Areas Of Expertise

Cardiac tumor treatment Catheter based approaches to structural heart disease Catheter based and open aortic disease treatments Cardiac valve disease Aortic surgery Cardiac tumor surgery Complex cardiac surgery
Education & Training

MD, Baylor College of Medicine
Residency, Baylor College of Medicine
Certificate, Healthcare Management, Rice University
Residency, Texas Heart Institute
Fellow, Harvard University

TAV-in-TAV in Failed Homograft: Redo TAVI in a Patient With 3 Previous Sternotomies
Hatab, T, Zaid, S, Wessly, P, Reardon, MJ, Atkins, MD, Faza, N, Little, SH, Kleiman, NS & Goel, SS 2023, , JACC: Case Reports, vol. 22, 101973. https://doi.org/10.1016/j.jaccas.2023.101973

Outcomes Based on Angiographic vs Functional Significance of Complex 3-Vessel Coronary Disease: FAME 3 Trial
FAME 3 Trial Investigators 2023, , JACC: Cardiovascular Interventions, vol. 16, no. 17, pp. 2112-2119. https://doi.org/10.1016/j.jcin.2023.06.023

Predicting 5-Year Clinical Outcomes After Transcatheter or Surgical Aortic Valve Replacement (a Risk Score from the SURTAVI Trial)
van Bergeijk, KH, Wykrzykowska, JJ, van Mieghem, NM, Windecker, S, Sondergaard, L, Gada, H, Li, S, Hanson, T, Deeb, GM, Voors, AA & Reardon, MJ 2023, , American Journal of Cardiology, vol. 200, pp. 78-86. https://doi.org/10.1016/j.amjcard.2023.05.036

Now You See Me Now You Don't: Subaortic Membrane Causing a Diagnostic Dilemma
Hatab, T, Zaid, S, Toro, S, Wessly, P, Malahfji, M, Faza, N, Little, SH, Kleiman, NS, Reardon, MJ & Goel, SS 2023, , JACC: Case Reports, vol. 18, 101916, pp. 101916. https://doi.org/10.1016/j.jaccas.2023.101916

TAVR in Bicuspid Aortic Stenosis: Current Evidence and Proposal for a Randomized Controlled Trial Design
Nuyens, P, De Backer, O, Sathananthan, J, Højsgaard Jørgensen, T, Treede, H, Leipsic, JA, Bax, JJ, Webb, JG, Mehran, R, Chen, M, Reardon, M, Leon, MB & Søndergaard, L 2023, , JACC: Cardiovascular Interventions, vol. 16, no. 13, pp. 1682-1687. https://doi.org/10.1016/j.jcin.2023.04.003

First-in-Human Multicenter Experience of the Newest Generation Supra-Annular Self-Expanding Evolut FX TAVR System
Zaid, S, Attizzani, GF, Krishnamoorthy, P, Yoon, SH, Palma Dallan, LA, Chetcuti, S, Fukuhara, S, Grossman, PM, Goel, SS, Atkins, MD, Kleiman, NS, Puri, R, Bakhtadze, B, Byrne, T, Ibrahim, AW, Grubb, KJ, Tully, A, Herrmann, HC, Faggioni, M, Ramlawi, B, Khera, S, Lerakis, S, Dangas, GD, Kini, AS, Sharma, SK, Reardon, MJ & Tang, GHL 2023, , JACC: Cardiovascular Interventions, vol. 16, no. 13, pp. 1626-1635. https://doi.org/10.1016/j.jcin.2023.05.004

Feasibility of redo-TAVI in self-expanding Evolut valves: a CT analysis from the Evolut Low Risk Trial substudy
Grubb, KJ, Shekiladze, N, Spencer, J, Perdoncin, E, Tang, GHL, Xie, J, Lisko, J, Sanchez, JZ, Lucas, LM, Sathananthan, J, Rogers, T, Michael Deeb, G, Fukuhara, S, Blanke, P, Leipsic, JA, Forrest, JK, Reardon, MJ & Gleason, P 2023, , EuroIntervention, vol. 19, no. 4, pp. E330-E339. https://doi.org/10.4244/EIJ-D-22-01125

Thirty-day and one-year outcomes of the Navitor transcatheter heart valve in patients with aortic stenosis: the prospective, multicentre, global PORTICO NG Study
Sondergaard, L, Walton, AS, Worthley, SG, Smith, D, Chehab, B, Manoharan, G, Yong, G, Bedogni, F, Bates, N & Reardon, MJ 2023, , EuroIntervention, vol. 19, no. 3, pp. 248-255. https://doi.org/10.4244/EIJ-D-22-01108

Indication Creep in Transcatheter Aortic Valve Implantation - Data or Desire?
Goel, SS & Reardon, MJ 2023, , JAMA Cardiology, vol. 8, no. 6, pp. 519-520. https://doi.org/10.1001/jamacardio.2023.0674

Transcatheter Mitral Valve Replacement Versus Medical Therapy for Secondary Mitral Regurgitation: A Propensity Score-Matched Comparison
Ludwig, S, Conradi, L, Cohen, DJ, Coisne, A, Scotti, A, Abraham, WT, Ben Ali, W, Zhou, Z, Li, Y, Kar, S, Duncan, A, Scott Lim, D, Adamo, M, Redfors, B, Muller, DWM, Webb, JG, Petronio, AS, Ruge, H, Nickenig, G, Sondergaard, L, Adam, M, Regazzoli, D, Garatti, A, Schmidt, T, Andreas, M, Dahle, G, Walther, T, Kempfert, J, Tang, GHL, Redwood, S, Taramasso, M, Praz, F, Fam, N, Dumonteil, N, Obadia, JF, Von Bardeleben, RS, Rudolph, TK, Reardon, MJ, Metra, M, Denti, P, Mack, MJ, Hausleiter, J, Asch, FM, Latib, A, Lindenfeld, J, Modine, T, Stone, GW & Granada, JF 2023, , Circulation: Cardiovascular Interventions, vol. 16, no. 6, pp. E013045. https://doi.org/10.1161/CIRCINTERVENTIONS.123.013045

Impact of Mitral Regurgitation Etiology on Mitral Surgery After Transcatheter Edge-to-Edge Repair: From the CUTTING-EDGE Registry
CUTTING-EDGE Investigators 2023, , JACC. Cardiovascular interventions, vol. 16, no. 10, pp. 1176-1188. https://doi.org/10.1016/j.jcin.2023.02.029

Influence of Cardiac Remodeling on Clinical Outcomes in Patients With Aortic Regurgitation
Malahfji, M, Crudo, V, Kaolawanich, Y, Nguyen, DT, Telmesani, A, Saeed, M, Reardon, MJ, Zoghbi, WA, Polsani, V, Elliott, M, Bonow, RO, Graviss, EA, Kim, R & Shah, DJ 2023, , Journal of the American College of Cardiology, vol. 81, no. 19, pp. 1885-1898. https://doi.org/10.1016/j.jacc.2023.03.001

Impact of aortic valve replacement in symptomatic low-risk patients with less than severe aortic stenosis
Ito, S, Laham, R, Nkomo, VT, Forrest, JK, Reardon, MJ, Little, SH, Mumtaz, M, Gada, H, Bajwa, T, Langholz, D, Heiser, J, Chawla, A, Jenson, B, Attizanni, G, Markowitz, AH, Huang, J & Oh, JK 2023, , Open Heart, vol. 10, no. 1, e002297. https://doi.org/10.1136/openhrt-2023-002297

Aortic Dissection During Pregnancy and Puerperium: Contemporary Incidence and Outcomes in the United States
Wang, Y, Yin, K, Datar, Y, Mohnot, J, Nodoushani, AY, Zhan, Y, Karlson, KJ, Edwards, NM, Reardon, MJ & Dobrilovic, N 2023, , Journal of the American Heart Association, vol. 12, no. 9, e028436, pp. e028436. https://doi.org/10.1161/JAHA.122.028436

3-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis
Low Risk Trial Investigators 2023, , Journal of the American College of Cardiology, vol. 81, no. 17, pp. 1663-1674. https://doi.org/10.1016/j.jacc.2023.02.017

Is it Time to Move Beyond STS and TVT Scores for Predicting TAVR Mortality?
Goel, SS & Reardon, MJ 2023, , Journal of the Society for Cardiovascular Angiography and Interventions, vol. 2, no. 3, 100633. https://doi.org/10.1016/j.jscai.2023.100633

SAPIEN 3 Ultra: better sealing, reduced paravalvular leak and a move in the right direction?
Reardon, MJ & Goel, SS 2023, , EuroIntervention, vol. 18, no. 17, pp. 1391-1392. https://doi.org/10.4244/EIJ-E-23-00009

Explant vs Redo-TAVR After Transcatheter Valve Failure: Mid-Term Outcomes From the EXPLANTORREDO-TAVR International Registry
Tang, GHL, Zaid, S, Kleiman, NS, Goel, SS, Fukuhara, S, Marin-Cuartas, M, Kiefer, P, Abdel-Wahab, M, De Backer, O, Søndergaard, L, Saha, S, Hagl, C, Wyler von Ballmoos, M, Bhadra, O, Conradi, L, Grubb, KJ, Shih, E, DiMaio, JM, Szerlip, M, Vitanova, K, Ruge, H, Unbehaun, A, Kempfert, J, Pirelli, L, Kliger, CA, Van Mieghem, N, Hokken, TW, Adrichem, R, Modine, T, Corona, S, Wang, L, Petrossian, G, Robinson, N, Meier, D, Webb, JG, Cheung, A, Ramlawi, B, Herrmann, HC, Desai, ND, Andreas, M, Mach, M, Waksman, R, Schults, CC, Ahmad, H, Goldberg, JB, Geirsson, A, Forrest, JK, Denti, P, Belluschi, I, Ben-Ali, W, Asgar, AW, Taramasso, M, Rovin, JD, Di Eusanio, M, Colli, A, Kaneko, T, Nazif, TN, Leon, MB, Bapat, VN, Mack, MJ, Reardon, MJ & Sathananthan, J 2023, , JACC: Cardiovascular Interventions, vol. 16, no. 8, pp. 927-941. https://doi.org/10.1016/j.jcin.2023.01.376

TAVR in 2023: Who Should Not Get It?
Bhogal, S, Rogers, T, Aladin, A, Ben-Dor, I, Cohen, JE, Shults, CC, Wermers, JP, Weissman, G, Satler, LF, Reardon, MJ, Yakubov, SJ & Waksman, R 2023, , American Journal of Cardiology, vol. 193, pp. 1-18. https://doi.org/10.1016/j.amjcard.2023.01.040

30-Day Clinical Outcomes of a Self-Expanding Transcatheter Aortic Valve: The International PORTICO NG Study
Reardon, MJ, Chehab, B, Smith, D, Walton, AS, Worthley, SG, Manoharan, G, Sultan, I, Yong, G, Harrington, K, Mahoney, P, Kleiman, N, Makkar, RR, Fontana, G, DeLago, A, Ramana, RK, Bates, N & Søndergaard, L 2023, , JACC: Cardiovascular Interventions, vol. 16, no. 6, pp. 681-689. https://doi.org/10.1016/j.jcin.2023.02.002